Systematic review of studies of productivity loss due to rheumatoid arthritis

Occupational Medicine

Volumn 56, Issue 1, 2006, Pages 18-27

  Burton, Wayne ^a,d   Morrison, Alan ^b   Maclean, Ross ^c   Ruderman, Eric ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SCRIBCO   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d NONE   (United States)

Author keywords

Economics; Employment; Epidemiology; Rheumatoid arthritis; Risk factors

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ABSENTEEISM; ADULT; AGE DISTRIBUTION; ARTICLE; BIBLIOGRAPHIC DATABASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; EMPLOYEE; EMPLOYER; EUROPEAN UNION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PRODUCTIVITY; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SCREENING TEST; SYSTEMATIC REVIEW; UNITED STATES; WORK DISABILITY; WORKPLACE;

ABSENTEEISM; ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; EFFICIENCY, ORGANIZATIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SICK LEAVE;

EID: 30844460981     PISSN: 09627480     EISSN: 14718405     Source Type: Journal    
DOI: 10.1093/occmed/kqi171     Document Type: Article

References (87)

1. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004;22:1-12.
2. Lajas C, Abasolo L, Bellajdel B et al. Costs and predictors of costs in rheumatoid arthritis: A prevalence-based study. Arthritis Rheum 2003;49:64-70.
3. Dunlop DD, Manheim LM, Yelin EH, Song J, Chang RW. The costs of arthritis. Arthritis Rheum 2003;49:101-113.
4. Leardini G, Salaffi F, Montanelli R, Gerzeli S, Canesi B. A multicenter cost-of-illness study on rheumatoid arthritis in Italy. Clin Exp Rheumatol 2002;20:505-515.
5. Pugner KM, Scott DI, Holmes JW, Hieke K. The costs of rheumatoid arthritis: An international long-term view. Semin Arthritis Rheum 2000;29:305-320.
6. Gabriel SE, Crowson CS, Luthra HS, Wagner JL, O'Fallon WM. Modeling the lifetime costs of rheumatoid arthritis. J Rheumatol 1999;26:1269-1274.
7. Clarke AE, Zowall H, Levinton C et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study. J Rheumatol 1997;24:1051-1060.
8. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 1997;24:43-48.
9. McIntosh E. The cost of rheumatoid arthritis. Br J Rheumatol 1996;35:781-790.
10. Yelin E. The costs of rheumatoid arthritis: Absolute, incremental and marginal estimates. J Rheumatol Suppl 1996;44:47-51.
11. Pincus T. The underestimated long term medical and economic consequences of rheumatoid arthritis. Drugs 1995; 50(Suppl. 1):1-14.
12. Allaire SH. Update on work disability in rheumatic diseases. Curr Opin Rheumatol 2001;13:93-98.
13. Allaire SH, Prashker MJ, Meenan RF. The costs of rheumatoid arthritis. Pharmacoeconomics 1994;6:513-522.
14. Backman CL. Employment and work disability in rheumatoid arthritis. Curr Opin Rheumatol 2004;16:148-152.
15. Cooper NJ. Economic burden of rheumatoid arthritis: A systematic review. Rheumatology (Oxford) 2000;39:28-33.
16. Leigh JP, Yasmeen S, Miller TR. Medical costs of fourteen occupational illnesses in the United States in 1999. Scand J Work Environ Health 2003;29:304-313.
17. Merkesdal S, Ruof J, Huelsemann JL et al. Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis. J Rheumatol 2001;28:657-661.
18. Silman AJ. Work characteristics, demographic factors and clinical variables could predict work disability in rheumatoid arthritis. Clin Exp Rheumatol 2001;19:247-248.
19. Sokka T. Work disability in early rheumatoid arthritis. Clin Exp Rheumatol 2003;21:S71-S74.
20. Sokka T, Pincus T. Markers for work disability in rheumatoid arthritis. J Rheumatol 2001;28:1718-1722.
21. Stewart WF, Ricci JA, Chee E, Morganstein D. Lost productive work time costs from health conditions in the United States: Results from the American Productivity Audit. J Occup Environ Med 2003;45:1234-1246.
22. Wang PS, Beck A, Berglund P et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med 2003;45:1303-1311.
23. Yelin E, Cisternas M, Pasta. D, Trupin L. Direct and Indirect Costs of Musculoskeletal Conditions in 1997: Total and Incremental Estimates. Revised Final Report (July 2003). http://ihps.ucsf.edu/arg/1997costofmuscfinal.pdf (last accessed 13 July 2004).
24. Zeidler H, Merkesdal S, Hulsemann JL. Early arthritis and rheumatoid arthritis in Germany. Clin Exp Rheumatol 2003;21:S106-S112.
25. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. J Am Med Assoc 2003;290: 2443-2454.
26. Muchmore L, Lynch WD, Gardner HH, Williamson T, Burke T. Prevalence of arthritis and associated joint disorders in an employed population and the associated health-care, sick leave, disability, and workers' compensation benefits cost and productivity loss of employers. J Occup Environ Med 2003;45:369-378.
27. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 2004;46:398-412.
28. Cisternas M, Yelin E, Trupin L, Helmick CG. Direct and indirect costs of arthritis and other rheumatic conditions - United States, 1997. MMWR Morb Mortal Wkly Rep 2003;52:1124-1127.
29. Murphy L, Cisternas M, Yelin E, Trupin L, Helmick CG. Update: Direct and indirect costs of arthritis and other rheumatic conditions - United States, 1997. MMWR Morb Mortal Wkly Rep 2004;53:388-389.
30. Hootman JM, Helmick CG, Langmaid G. Public health and aging: Projected prevalence of self-reported arthritis or chronic joint symptoms among persons aged >65 years - United States, 2005-2030. MMWR Morb Mortal Wkly Rep 2003;52:489-491.
31. Bolen J, Helmick CG, Sacks JJ, Langmaid G. Prevalence of doctor-diagnosed arthritis and possible arthritis - 30 states, 2002. MMWR Morb Mortal Wkly Rep 2004;53: 383-386.
32. Mitchell JM, Burkhauser RV, Pincus T. The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum 1988;31:348-357.
33. Pincus T, Mitchell JM, Burkhauser RV. Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: comparisons with rheumatoid arthritis. J Clin Epidemiol 1989;42:449-457.
34. Albers JM, Kuper HH, van Riel PL et al. Socio-economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology (Oxford) 1999;38:423-430.
35. Allaire SH, Anderson JJ, Meenan RF. Reducing work disability associated with rheumatoid arthritis: Identification of additional risk factors and persons likely to benefit from intervention. Arthritis Care Res 1996;9: 349-357.
36. Backman CL, Kennedy SM, Chalmers A, Singer J. Participation in paid and unpaid work by adults with rheumatoid arthritis. J Rheumatol 2004;31:47-56.
37. Barrett EM, Scott DG, Wiles NJ, Symmons DP. The impact of rheumatoid arthritis on employment status in the early years of disease: A UK community-based study. Rheumatology (Oxford) 2000;39:1403-1409.
38. Birnbaum HG, Barton M, Greenberg PE et al. Direct and indirect costs of rheumatoid arthritis to an employer. J Occup Environ Med 2000;42:588-596.
39. Borg G, Allander E, Berg E, Brodin U, From A, Trang L. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. J Rheumatol 1991;18:1015-1020.
40. Callahan LF, Bloch DA, Pincus T. Identification of work disability in rheumatoid arthritis: Physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 1992;45:127-138.
41. Chorus AM, Miedema HS, Wevers CW, van der Linden S. Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis. Ann Rheum Dis 2001;60: 1025-1032.
42. Dadoniene J, Stropuviene S, Venalis A, Boonen A. High work disability rate among rheumatoid arthritis patients in Lithuania. Arthritis Rheum 2004;51:433-439.
43. De Roos AJ, Callahan LF. Differences by sex in correlates of work status in rheumatoid arthritis patients. Arthritis Care Res 1999;12:381-391.
44. Doeglas D, Suurmeijer T, Krol B, Sanderman R, van Leeuwen M, van Rijswijk M. Work disability in early rheumatoid arthritis. Ann Rheum Dis 1995;54:455-460.
45. Fex E, Larsson BM, Nived K, Eberhardt K. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 1998;25:44-50.
46. Holte HH, Tambs K, Bjerkedal T. Becoming a disability pensioner with rheumatoid arthritis in Norway 1971-1990. J Rheumatol 2001;28:54-61.
47. Jantti J, Aho K, Kaarela K, Kautiainen H. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: A 20 year study. Rheumatology (Oxford) 1999;38:1138-1141.
48. Kaarela K, Lehtinen K, Luukkainen R. Work capacity of patients with inflammatory joint diseases. An eight-year follow-up study. Scand J Rheumatol 1987;16: 403-406.
49. Lacaille D, Sheps S, Spinelli JJ, Chalmers A, Esdaile JM. Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum 2004;51:843-852.
50. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C. The economic burden associated with osteoarthritis, rheumatoid arthritis and hypertension: A comparative study. Ann Rheum Dis 2004;63:395-401.
51. Makisara GL, Makisara P. Prognosis of functional capacity and work capacity in rheumatoid arthritis. Clin Rheumatol 1982;1:117-125.
52. Mau W, Bornmann M, Weber H. Work disability work in the first year of chronic polyarthritis. A comparison with members of the legal health health insurance. Z Rheumatol 1997;56:1-7 [in German].
53. Mau W, Bornmann M, Weber H, Weidemann HF, Hecker H, Raspe HH. Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: Results of a tree structured analysis using RECPAM. Br J Rheumatol 1996;35:652-629.
54. Meenan RF, Yelin EH, Henke CJ, Curtis DL, Epstein WV. The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs. Arthritis Rheum 1978;21: 827-833.
55. Meenan RF, Yelin EH, Nevitt M, Epstein WV. The impact of chronic disease: A sociomedical profile of rheumatoid arthritis. Arthritis Rheum 1981;24:544-549.
56. Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: Composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 2001;44:528-534.
57. Newhall-Perry K, Law NJ, Ramos B et al. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. J Rheumatol 2000;27:1156-1163.
58. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability and increased mortality in seventy five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-872.
59. Reisine S, Fifield J, Walsh SJ, Feinn R. Factors associated with continued employment among patients with rheumatoid arthritis: A survival model. J Rheumatol 2001;28: 2400-2408.
60. Reisine S, McQuillan J, Fifield J. Predictors of work disability in rheumatoid arthritis patients. A five-year follow-up. Arthritis Rheum 1995;38:1630-1637.
61. Reisine ST, Grady KE, Goodenow C, Fifield J. Work disability among women with rheumatoid arthritis. The relative importance of disease, social, work, and family factors. Arthritis Rheum 1989;32:538-543.
62. Ruof J, Hulsemann JL, Mittendorf T et al. Costs of rheumatoid arthritis in Germany: A micro-costing approach based on healthcare payer's data sources. Ann Rheum Dis 2003;62:544-549.
63. Sokka T, Kautiainen H, Mottonen T, Hannonen P. Work disability in rheumatoid arthritis 10 years after the diagnosis. J Rheumatol 1999;26:1681-1685.
64. van Jaarsveld CH, Jacobs JW, Schrijvers AJ, van Albada-Kuipers GA, Hofman DM, Bijlsma JW. Effects of rheumatoid arthritis on employment and social participation during the first years of disease in The Netherlands. Br J Rheumatol 1998;37:848-853.
65. Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-2117.
66. Yelin E, Henke C, Epstein W. The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 1987;30: 507-512.
67. Young A, Dixey J, Kulinskaya E et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002;61:335-340.
68. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The role of health risk factors and disease on worker productivity. J Occup Environ Med 1999;41: 863-877.
69. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The economic burden of lost productivity due to migraine headache: A specific worksite analysis. J Occup Environ Med 2002;44:523-529.
70. Mau W, Bornmann M, Weber H. Indicators of work incapacity in the first year of chronic polyarthritis. Z Rheumatol 1996;55:233-240 [in German].
71. Kanji GK. 100 Statistical Tests. London: SAGE Publications Ltd., 1999.
72. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-243.
73. U.S. Department of Labor. Bureau of Labor Statistics. Tables from Employment and Earnings. B-1. Employees on Nonfarm Payrolls by Major Industry Sector, Historical. http://www.bls.gov/ces/home.htm#ee (2 December 2004, date last accessed).
74. Puolakka K, Kautiainen H, Mottonen T et al. Predictors of productivity loss in early rheumatoid arthritis: A 5 year follow up study. Ann Rheum Dis 2005;64:130-133.
75. Verstappen SM, Boonen A, Bijlsma JW et al. Working status among Dutch patients with rheumatoid arthritis: Work disability and working conditions. Rheumatology (Oxford) 2004;44:202-206.
76. Chorus AM, Miedema HS, Wevers CJ, van Der Linden S. Labour force participation among patients with rheumatoid arthritis. Ann Rheum Dis 2000;59:549-554.
77. Abdel-Nasser AM, Rasker JJ, Valkenburg HA. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin Arthritis Rheum 1997;27: 123-140.
78. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269-281.
79. Silman AJ. The changing face of rheumatoid arthritis: Why the decline in incidence? Arthritis Rheum 2002;46: 579-581.
80. de Croon EM, Sluiter JK, Nijssen TF, Dijkmans BA, Lankhorst GJ, Frings-Dresen MH. Predictive factors of work disability in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 2004;63:1362-1367.
81. Maini RN, Breedveld FC, Kalden JR et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004;50:1051-1065.
82. St Clair EW, van der Heijde DM, Smolen JS et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial. Arthritis Rheum 2004;50:3432-3443.
83. Kavanaugh A, Han C, Bala M. Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritis. J Rheumatol 2004;31:849-855.
84. Bresnihan B. Anakinra as a new therapeutic option in rheumatoid arthritis: Clinical results and perspectives. Clin Exp Rheumatol 2002;20:S32-S34.
85. Bresnihan B, Cobby M. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology (Oxford) 2003;42(Suppl. 2):iI22-ii28.
86. Yelin E, Trupin L, Katz P, Lubeck D, Rush S, Wanke L. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis. Arthritis Rheum 2003;48:3046-3054.
87. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: A patient-reported outcomes perspective. Pharmacoeconomics 2004;22:225-244.